Go Pro
NASDAQ:ULBI

Ultralife (ULBI) Stock Price, News & Analysis

Ultralife logo
$5.19 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$5.22 +0.02 (+0.48%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Ultralife Stock (NASDAQ:ULBI)

Advanced

Key Stats

Today's Range
$5.16
$5.28
50-Day Range
$5.16
$7.76
52-Week Range
$4.90
$8.72
Volume
35,579 shs
Average Volume
29,697 shs
Market Capitalization
$86.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements. Its Communications Systems segment offers tactical communications solutions, including voice and data transmission systems, power management units and air purification systems primarily for military and public safety organizations.

Founded in the late 1980s and headquartered in Newark, New York, Ultralife has built a reputation for delivering rugged, reliable energy and communication solutions that comply with stringent defense and industrial standards. Over the years, the company has invested in research and development to expand its product portfolio, pursue higher energy density chemistries and improve battery management technologies. Ultralife’s manufacturing facilities and design centers are ISO-certified and employ automated production processes to maintain quality, traceability and consistency across all product lines.

Ultralife serves customers around the globe, with sales and support operations in North America, Europe and Asia. Its energy solutions power critical applications such as battlefield radios, unmanned vehicles, medical monitoring devices and electric vehicle charging systems, while its communications products are used in environments that demand secure, continuous voice and data connectivity. The company’s customer base includes major defense contractors, equipment manufacturers and end users in the public safety sector.

Ultralife is led by an experienced management team and board of directors with deep expertise in battery technology, electronics engineering and global supply chain management. The company continues to pursue strategic collaborations and acquisitions to enhance its technology offerings, expand its geographic footprint and capture new growth opportunities in renewable energy and next-generation communications markets.

AI Generated. May Contain Errors.

Ultralife Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
21st Percentile Overall Score

ULBI MarketRank™: 

Ultralife scored higher than 21% of companies evaluated by MarketBeat, and ranked 572nd out of 653 stocks in the industrials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ultralife has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Ultralife has only been the subject of 1 research reports in the past 90 days.

  • Read more about Ultralife's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ultralife is -10.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ultralife is -10.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Ultralife has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Ultralife's valuation and earnings.
  • Percentage of Shares Shorted

    0.73% of the float of Ultralife has been sold short.
  • Short Interest Ratio / Days to Cover

    Ultralife has a short interest ratio ("days to cover") of 2.49, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Ultralife has recently decreased by 1.39%, indicating that investor sentiment is improving.
  • Dividend Yield

    Ultralife does not currently pay a dividend.

  • Dividend Growth

    Ultralife does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Ultralife this week, compared to 1 article on an average week.
  • MarketBeat Follows

    Only 1 people have added Ultralife to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $714,928.00 in company stock, which represents 0.8268% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Ultralife insiders have bought more of their company's stock than they have sold. Specifically, they have bought $714,928.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    42.90% of the stock of Ultralife is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    30.68% of the stock of Ultralife is held by institutions.

  • Read more about Ultralife's insider trading history.
Receive ULBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ultralife and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ULBI Stock News Headlines

Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
Ultralife Stock Price History
Ultralife Corporation Reports First Quarter Results
See More Headlines

ULBI Stock Analysis - Frequently Asked Questions

Ultralife's stock was trading at $5.72 at the beginning of 2026. Since then, ULBI stock has decreased by 9.3% and is now trading at $5.19.

Ultralife Corporation (NASDAQ:ULBI) announced its quarterly earnings results on Friday, May, 8th. The technology company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by $0.18. The technology company earned $47.45 million during the quarter, compared to analysts' expectations of $52.40 million. Ultralife had a positive trailing twelve-month return on equity of 1.15% and a negative net margin of 4.37%.
Read the conference call transcript
.

The following companies are subsidiaries of Ultralife: ABLE New Energy Co. Limited, Accutronics Ltd., CLB Inc., Southwest Electronic Energy Corporation, Ultralife Batteries India Private Limited, Ultralife Batteries (UK) LTD, Ultralife Energy Services Corporation, and Ultralife UK LTD.

Shares of ULBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ultralife investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL) and Adobe (ADBE).

Company Calendar

Last Earnings
5/08/2026
Today
8/03/2026
Next Earnings (Estimated)
8/07/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Electrical Equipment
Sub-Industry
Electrical Components & Equipment
Current Symbol
NASDAQ:ULBI
CIK
875657
Employees
560
Year Founded
1990

Profitability

EPS (Trailing Twelve Months)
($0.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.90 million
Net Margins
-4.37%
Pretax Margin
-6.13%
Return on Equity
1.15%
Return on Assets
0.70%

Debt

Debt-to-Equity Ratio
0.34
Current Ratio
2.56
Quick Ratio
1.23

Sales & Book Value

Annual Sales
$191.16 million
Price / Sales
0.45
Cash Flow
$0.60 per share
Price / Cash Flow
8.63
Book Value
$7.82 per share
Price / Book
0.66

Miscellaneous

Outstanding Shares
16,660,000
Free Float
9,511,000
Market Cap
$86.47 million
Optionable
No Data
Beta
0.80

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:ULBI) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners